Joan Gascó

Joan Gascó

Auto-generated profile, based on publicly available information

Joan Gascó

Son Espases University Hospital, Majorca, Spain

Research Focus & Metrics

Academic Career Length

38Years (1989-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2011 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Open access
PDF file
LGLaura Garcia-Sureda
Laura Garcia-Sureda
ADAntonio Doménech-Sánchez
Antonio Doménech-Sánchez
MBMariette Barbier
Mariette Barbier
Carlos JuanCarlos Juan
Carlos Juan
JGJoan Gascó
Joan Gascó
SASebastián Albertí
Sebastián Albertí
Clinical isolates of Klebsiella pneumoniae resistant to carbapenems are being isolated with increasing frequency. Loss of the expression of the major nonspecific porins OmpK35/36 is a frequent feature in these isolates. In this study, we looked for porins that could compensate for the loss of the major porins in carbapenem-resistant organisms. Comparison of the outer membrane proteins from two K. pneumoniae clinical isogenic isolates that are susceptible (KpCS-1) and resistant (KpCR-1) to carbapenems revealed the absence of OmpK35/36 and the presence of a new 26-kDa protein in the resistant isolate. An identical result was obtained when another pair of isogenic isolates that are homoresistant (Kpn-3) and heteroresistant (Kpn-17) to carbapenems were compared. Mass spectrometry and DNA sequencing analysis demonstrated that this new protein, designated OmpK26, is a small monomeric oligogalacturonate-specific porin that belongs to the KdgM family of porins. Insertion-duplication mutagenesis of the OmpK26 coding gene, yjhA , in the carbapenem-resistant, porin-deficient isolate KpCR-1 caused the expression of OmpK36 and the reversion to the carbapenem-susceptible phenotype, suggesting that OmpK26 is indispensable for KpCR-1 to lose OmpK36 and become resistant to these antibiotics. Moreover, loss of the major porin and expression of OmpK26 reduced in vitro fitness and attenuated virulence in a murine model of acute systemic infection. Altogether, these results indicate that expression of the oligogalacturonate-specific porin OmpK26 compensates for the absence of OmpK35/36 and allows carbapenem resistance in K. pneumoniae but cannot restore the fitness of the microorganism.

1 March 2005 in FEMS Microbiology Ecology
Verified
Journal Article
Closed access
MGMargarita Gomila
Margarita Gomila
JGJoan Gascã³
Joan Gascã³
ABAntonio Busquets
Antonio Busquets
JGJosã© Gil
Josã© Gil
RBRosario Bernabeu
Rosario Bernabeu
JLJorge Lalucat
Jorge Lalucat
Water used to prepare haemodialysis fluid is not sterile, and its microbiological control is important for the prevention of haemodialysis-associated illness. Bacterial populations inhabiting a distribution system for haemodialysis water were studied over an 18-month period. 203 planktonic bacteria isolated on R2A medium were identified by restriction analysis and sequencing of 16S rRNA gene. A diverse bacterial community was detected, containing predominantly Gram-negative members of the Alphaproteobacteria and Betaproteobacteria, as well as representatives of the genus Mycobacterium. Ecological and clinical consequences are discussed: bacteria from the genera Novosphingobium, Pseudomonas and Sphingomonas have been described in the build-up of biofilms, and others like Acinetobacter, Mycobacterium or Brevibacterium may represent a health risk to patients under haemodialysis treatment.

18 March 2016 in Transfusion
Verified
Journal Article
Closed access
PDF file
TJTeresa Jimenez‐Marco
Teresa Jimenez‐Marco
RFRoser Fisa
Roser Fisa
EGEnrique Girona‐Llobera
Enrique Girona‐Llobera
BCBeatriz Cancino Cancino-Faure
Beatriz Cancino Cancino-Faure
MTMiriam Tomás‐Pérez
Miriam Tomás‐Pérez
CRCristina Riera
Cristina Riera

1 December 2008 in International Journal of Systematic and Evolutionary Microbiology
Verified
Journal Article
Closed access
PDF file
MGMargarita Gomila
Margarita Gomila
ARAntonio Ramirez
Antonio Ramirez
JGJoan Gascó
Joan Gascó
JLJorge Lalucat
Jorge Lalucat
Six mycobacterial isolates from haemodialysis water, conforming a homogeneous phylogenetic group in a previous multigenic analysis, were classified taxonomically. Physiological and biochemical characterization, as well as DNA–DNA hybridizations, demonstrated that the isolates were facultatively autotrophic, aerobic and hydrogen-oxidizing bacteria, representing a novel species in the rapid growing Mycobacterium group, for which the name Mycobacterium llatzerense sp. nov. is proposed. The type strain is MG13T (=CECT 7273T=CCUG 54744T).

8 March 2007 in Nephrology Dialysis Transplantation
Verified
Journal Article
Closed access
ASA. Segarra
A. Segarra
MAM L. Amoedo
M L. Amoedo
JGJ. M Martinez Garcia
J. M Martinez Garcia
SPS. Pons
S. Pons
MPM. Praga
M. Praga
LPL. Piera
L. Piera
Studies of mycophenolate mofetil (MMF) in primary glomerulonephritis have varied in their inclusion criteria, regimen and follow-up compromising assessments of efficacy and optimal dose. This multicentre study analysed the safety and efficacy of MMF monotherapy in a large cohort with primary glomerulonephritis that was resistant to other conventional therapies. A total of 98 patients with biopsy-proven primary glomerulonephritis resistant to other drugs received MMF monotherapy for 1 year. Primary outcome measures were urinary protein excretion and the number of patients with complete or partial remission of proteinuria. Secondary analyses were time to remission and changes in the slope of creatinine clearance. Fifty-four percent of the patients achieved either complete or partial remission of proteinuria with no significant differences between glomerulonephritis types. Median (range) dose of MMF was 2 g/day (1.5-2 g/day) Mean (SD) treatment time to remission was 141.5 (+/-61.1) days with no significant differences between glomerulonephritis types. Serum albumin increased (P50% of the patients who do not have other treatment options. The response to therapy is largely influenced by a preserved renal function and requires sustained MMF treatment.

1 November 2006 in Kidney International
Verified
Journal Article
Closed access
MGMargarita Gomila
Margarita Gomila
JGJ. Gascó
J. Gascó
JGJ. Gil
J. Gil
RBR. Bernabeu
R. Bernabeu
VIV. Iñigo
V. Iñigo
JLJorge Lalucat
Jorge Lalucat